13F HOLDINGS REPORT
Essex Woodlands Management, Inc.
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001398344-24-014608
Total Value
$306.7M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MIMEDX GROUP, INC. | MDXG | 28,195,249 | $195.4M | 63.71% |
| 2 | BIOVENTUS | BVS | 13,021,324 | $74.9M | 24.41% |
| 3 | TELA BIO, INC. | TELA | 4,110,709 | $19.3M | 6.30% |
| 4 | EYEPOINT PHARMACEUTICALS INC | EYPT | 1,551,521 | $13.5M | 4.40% |
| 5 | MEDICINOVA INC | MNOV | 1,105,941 | $1.6M | 0.52% |
| 6 | REVANCE THERAPEUTICS INC | 761330109 | 457,085 | $1.2M | 0.38% |
| 7 | VENUS CONCEPT, INC. | VERO | 1,089,190 | $852,836 | 0.28% |